Peter Beck

CEO Peter Beck sold 3,275,779 shares for $286,410,195.56 across three days (2026-07-06 to 2026-07-08) under a 10b5-1 plan.

Peter Beck executed 24 separate sales totaling 3,275,779 shares for $286,410,195.56 on a scheduled 10b5-1 trading plan adopted on 2026-03-27, reducing his RKLB holdings by -65.5% from 5,000,000 shares to 1,724,221 shares. The multi-day sale was conducted at a blended average price of $87.43, while the stock currently trades at $83.35 (down -44.8% from its 52-week high of $151.00 and down -26.7% over the prior 30 days). Beck's prior five sales at RKLB all occurred on 2026-03-02 and showed 90-day returns ranging from +103.2% to +114.7%, while his cross-ticker track record of 20 prior sells averaged 90-day returns of +44.1%. Because this transaction is pre-scheduled under a 10b5-1 plan rather than discretionary, the sale reflects a contractual commitment executed at market prices rather than a signal of recent conviction or market timing. The scale of the divestiture and the company's unprofitable status (full-year net income negative, latest quarter net income $-45.0M) against $200,348,000 in quarterly revenue merit scrutiny of whether prior transaction planning reflected different market conditions.

CEO Peter Beck liquidates entire 2,500,000 share stake ($141.1M) via 14 sales over two days under pre-arranged 10b5-1 plan.

Peter Beck, CEO of Rocket Lab Corp, executed 14 separate sales totaling 2,500,000 shares for $141,105,495.96 on December 15–16, 2025, with prices ranging from $53.21 to $64.31 per share and a blended average of $56.44. This transaction represents a complete exit—100% of pre-transaction holdings reduced to zero shares post-transaction. The sales were conducted pursuant to a pre-arranged 10b5-1 trading plan adopted on 2025-06-13, meaning the execution was scheduled rather than discretionary. For investors evaluating management commitment and capital allocation, a complete liquidation of founder/CEO equity by the company's chief executive warrants attention to the terms under which the plan was adopted and the company's forward guidance.

CEO Beck Peter sold 2,500,000 shares (2.50M) for $127,453,446.41 ($127.5M) on 2025-09-15/16 via pre-arranged 10b5-1 plan; post-transaction holdings: 2,500,000 shares (2.50M)

Beck Peter, President, CEO and Chairman of Rocket Lab Corp, executed 8 separate sales totaling 2,500,000 shares (2.50M shares) for $127,453,446.41 ($127.5M) at prices ranging from $48.04 to $54.96 per share across September 15–16, 2025, reducing his holdings from 5,000,000 shares (5.00M shares) to 2,500,000 shares (2.50M shares)—a reduction of 50.0% of pre-transaction holdings. This transaction is part of a pre-arranged 10b5-1 trading plan adopted on 2025-06-13, meaning the sales were scheduled, not discretionary, and therefore do not reflect a contemporaneous signal about the CEO's assessment of current value. The scale of this divestment—liquidating exactly half of his position—warrants investor review of the underlying transaction details and any concurrent company announcements or filings that may clarify the context for the plan's design.